IMMUNEX CORPORATION – Trademark Portfolio

Entity Type: 03

IMMUNEX CORPORATION holds 98 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 51 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 11 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include FLAG, ENBREL, LEUKINE, VECTIBIX, and ANTI-FLAG. The owner is based in THOUSAN OAKS, CA.